Study investigators cautioned against routine use of the device in complex percutaneous coronary interventions and to treat ...

Two separate randomized trials of Johnson & Johnson’s miniaturized Impella heart pumps failed to illustrate the devices’ ...

Randomized trials neutral for pump device in complex elective cases, STEMI with reperfusio ...

The results challenge the rapid growth of Impella support during high-risk PCI. Investigators say a reckoning is needed.

Johnson & Johnson subsidiary Abiomed recalled its Impella left sided blood pumps for risk that the devices could perforate the heart during a procedure. The recall began on Dec. 27 with Abiomed ...

Results of lung impedance-guided therapy in HFpEF also anticipated this weekend ...

The U.S. FDA posted notice of a medical device correction of Abiomed Inc.'s Impella series of left-side blood pumps because of the risk of perforation of the left ventricle during device placement.

PHILADELPHIA -- The Impella mechanical support device, frequently used in patients in cardiogenic shock who are undergoing percutaneous coronary interventions, was more expensive than intra-aortic ...